Electrophysiology Research Laboratory, Texas Heart Institute/St. Luke's Episcopal Hospital, Houston, TX, USA.
Circ Arrhythm Electrophysiol. 2012 Oct;5(5):1017-26. doi: 10.1161/CIRCEP.111.969220. Epub 2012 Aug 28.
Defects of cytoarchitectural proteins can cause left ventricular noncompaction, which is often associated with conduction system diseases. We have previously identified a p.D117N mutation in the LIM domain-binding protein 3-encoding Z-band alternatively spliced PDZ motif gene (ZASP) in a patient with left ventricular noncompaction and conduction disturbances. We sought to investigate the role of p.D117N mutation in the LBD3 NM_001080114.1 isoform (ZASP1-D117N) for the regulation of cardiac sodium channel (Na(v)1.5) that plays an important role in the cardiac conduction system.
Effects of ZASP1-wild-type and ZASP1-D117N on Na(v)1.5 were studied in human embryonic kidney-293 cells and neonatal rat cardiomyocytes. Patch-clamp study demonstrated that ZASP1-D117N significantly attenuated I(Na) by 27% in human embryonic kidney-293 cells and by 32% in neonatal rat cardiomyocytes. In addition, ZASP1-D117N rightward shifted the voltage-dependent activation and inactivation in both systems. In silico simulation using Luo-Rudy phase 1 model demonstrated that altered Na(v)1.5 function can reduce cardiac conduction velocity by 28% compared with control. Pull-down assays showed that both wild-type and ZASP1-D117N can complex with Na(v)1.5 and telethonin/T-Cap, which required intact PDZ domains. Immunohistochemical staining in neonatal rat cardiomyocytes demonstrates that ZASP1-D117N did not significantly disturb the Z-line structure. Disruption of cytoskeletal networks with 5-iodonaphthalene-1-sulfonyl homopiperazine and cytochalasin D abolished the effects of ZASP1-D117N on Na(v)1.5.
ZASP1 can form protein complex with telethonin/T-Cap and Na(v)1.5. The left ventricular noncompaction-specific ZASP1 mutation can cause loss of function of Na(v)1.5, without significant alteration of the cytoskeletal protein complex. Our study suggests that electric remodeling can occur in left ventricular noncompaction subject because of a direct effect of mutant ZASP on Na(v)1.5.
细胞结构蛋白的缺陷可导致左心室心肌致密化不全,常伴有传导系统疾病。我们之前在一名左心室心肌致密化不全伴传导障碍的患者中发现了 LIM 结构域结合蛋白 3 编码的 Z 带交替拼接 PDZ 基序基因(ZASP)中的 p.D117N 突变。我们试图研究 LBD3 NM_001080114.1 异构体(ZASP1-D117N)中 p.D117N 突变对心脏钠离子通道(Nav1.5)的调节作用,Nav1.5 在心脏传导系统中起重要作用。
在人胚肾 293 细胞和新生大鼠心肌细胞中研究了 ZASP1-野生型和 ZASP1-D117N 对 Nav1.5 的影响。膜片钳研究表明,ZASP1-D117N 使人类胚胎肾 293 细胞中的 INa减少 27%,使新生大鼠心肌细胞中的 INa减少 32%。此外,ZASP1-D117N 使两个系统中的电压依赖性激活和失活均向右移。使用 Luo-Rudy 相 1 模型进行的计算机模拟表明,与对照相比,改变的 Nav1.5 功能可使心脏传导速度降低 28%。拉下测定表明,野生型和 ZASP1-D117N 均可与 Nav1.5 和 telethonin/T-Cap 形成复合物,这需要完整的 PDZ 结构域。新生大鼠心肌细胞的免疫组化染色表明,ZASP1-D117N 不会显著扰乱 Z 线结构。用 5-碘萘-1-磺酰基同哌嗪和细胞松弛素 D 破坏细胞骨架网络,消除了 ZASP1-D117N 对 Nav1.5 的作用。
ZASP1 可以与 telethonin/T-Cap 和 Nav1.5 形成蛋白复合物。左心室心肌致密化不全特异性 ZASP1 突变可导致 Nav1.5 功能丧失,而细胞骨架蛋白复合物无明显改变。我们的研究表明,由于突变 ZASP 对 Nav1.5 的直接作用,左心室心肌致密化不全患者可能会发生电重构。